CORC

在结果中检索

CORC

浏览/检索结果: 共140条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Discovery of a Pyrimidinedione Derivative as a Potent and Orally Bioavailable Axl Inhibitor 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 7, 页码: 3956-3975
作者:  Zhang, Hefeng;  Peng, Xia;  Dai, Yang;  Shao, Jingwei;  Ji, Yinchun
收藏  |  浏览/下载：16/0  |  提交时间：2021/06/11
Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity 期刊论文
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2019, 卷号: 33, 期号: 8, 页码: 775-785
作者:  Zhu, Kongkai;  Shao, Jingwei;  Tao, Hongrui;  Yan, Xue;  Luo, Cheng
收藏  |  浏览/下载：12/0  |  提交时间：2020/07/01
Response of aggregate associated organic carbon, nitrogen and phosphorous to re-vegetation in agro-pastoral ecotone of northern China 期刊论文
GEODERMA, 2019, 期号: 341, 页码: 172-180
作者:  Yufei Yao;  Nannan Ge;  Si Yu;  Xiaorong Wei;  Xiang Wang
收藏  |  浏览/下载：19/0  |  提交时间：2020/06/11
Discovery of 2-substituted-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamide as potent and selective protein arginine methyltransferases 5 inhibitors: Design, synthesis and biological evaluation 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 164, 页码: 317-333
作者:  Shao, Jingwei;  Zhu, Kongkai;  Du, Daohai;  Zhang, Yuanyuan;  Tao, Hongrui
收藏  |  浏览/下载：35/0  |  提交时间：2020/07/01
MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 110
作者:  Li, Jingwei;  Shao, Wei;  Feng, Huian
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer 期刊论文
MOLECULAR CARCINOGENESIS, 2019, 卷号: 58, 页码: 144-155
作者:  Zheng, Ning;  Liu, Weiqun;  Chen, Jiahang;  Li, Bifei;  Liu, Jian
收藏  |  浏览/下载：13/0  |  提交时间：2019/11/21
Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies 期刊论文
CURRENT CANCER DRUG TARGETS, 2019, 卷号: 19, 页码: 245-256
作者:  Zou, Junjie;  Lin, Juanfang;  Li, Chao;  Zhao, Ruirui;  Fan, Lulu
收藏  |  浏览/下载：25/0  |  提交时间：2019/11/21
Current Cancer Drug Development Strategies 期刊论文
CURRENT CANCER DRUG TARGETS, 2019, 卷号: 19, 页码: 243-244
作者:  Shao, Jingwei;  Gao, Yu
收藏  |  浏览/下载：9/0  |  提交时间：2019/11/21
High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations 期刊论文
2019, 卷号: 142, 期号: 1, 页码: 23-34
作者:  Hong, Tao;  Yan, Yupeng;  Li, Jingwei;  Radovanovic, Ivan;  Ma, Xiangyuan
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4 alpha 期刊论文
THERANOSTICS, 2019, 卷号: 9, 期号: 9, 页码: 2606-2617
作者:  Zheng, Bai-Nan;  Ding, Chen-Hong;  Chen, Shi-Jie;  Zhu, Kongkai;  Shao, Jingwei
收藏  |  浏览/下载：10/0  |  提交时间：2020/07/01

©版权所有 ©2017 CSpace - Powered by CSpace